Elevated plasma Homocysteine (HCY) levels predict accelerated chronic diseases. A clinical limitation has been leakage into plasma of red cell HCY starting shortly after phlebotomy. A more stable specimen is needed especially at lower values.
Specimens (N=20) were collected in EDTA tubes (current preferred specimen) and a novel cell preservative. Specimens were stored at 4±1°C until analysis. Plasma was isolated and analyzed at 0.5, 4, 8, 24, 48, 72, and 96 hours after phlebotomy using a Diazyme™ Analyzer 700 and statistically analyzed by one‐way ANOVA.
HCY levels started to increase within 30 minutes in EDTA specimens while the new cell preservative sample values were stable for at least 48 hours. Indeed initial HCY levels in EDTA samples were typically 32% higher the new preservative (p<0.0001). This suggests that HCY is released to plasma from red blood cells in EDTA samples starting minutes after phlebotomy and less so in EAB cell preservative.
Initial and more precise HCY can be measured and maintained for at least 48 hours when the EAB cell preservative is used as specimen anticoagulant. EDTA in contrast allows HCY increase that starts within minutes after blood draw. The reported cell preservative allows a more stable and accurate HCY assay for this predictive biomarker. More studies are needed to confirm the clinical and global predictive significance of this biomarker.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.